Boehringer Ingelheim Venture

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Boehringer Ingelheim Venture — overview

About

Boehringer Ingelheim Venture is the corporate venture arm of Boehringer Ingelheim, a global pharmaceutical company. The firm makes early-stage investments worldwide and channels its investments into innovative pharmaceutical and medical technologies companies, with a focus on next-generation vaccines, NBEs, and regenerative medicine.

Boehringer Ingelheim Venture - known decision makers (24)

Position	Location	Asset Class
Executive Director / Investment Manager	Ingelheim am Rhein, Germany	PE
Executive Director / Investment Manager, BI Venture Fund, Head of Venture Fund US	Ingelheim am Rhein, Germany	PE
Global Head of Making More Health	Ingelheim am Rhein, Germany	PE
Global Head of the Boehringer Ingelheim Venture Fund	Ingelheim am Rhein, Germany	PE
Global Head of Venture Fund	Ingelheim am Rhein, Germany	PE

Showing 5 of 24 known decision makers Boehringer Ingelheim Venture

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo